Fig. 1From: Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literaturePlatelet count and therapy for autoimmune cytopenia following HSCT in patient 1 (a) and patient 2 (b)Back to article page